Functional and Structural Characterization of ClC-1 and Nav1.4 Channels Resulting from CLCN1 and SCN4A Mutations Identified Alone and Coexisting in Myotonic Patients
Open Access
- 11 February 2021
- Vol. 10 (2), 374
- https://doi.org/10.3390/cells10020374
Abstract
Non-dystrophic myotonias have been linked to loss-of-function mutations in the ClC-1 chloride channel or gain-of-function mutations in the Nav1.4 sodium channel. Here, we describe a family with members diagnosed with Thomsen’s disease. One novel mutation (p.W322*) in CLCN1 and one undescribed mutation (p.R1463H) in SCN4A are segregating in this family. The CLCN1-p.W322* was also found in an unrelated family, in compound heterozygosity with the known CLCN1-p.G355R mutation. One reported mutation, SCN4A-p.T1313M, was found in a third family. Both CLCN1 mutations exhibited loss-of-function: CLCN1-p.W322* probably leads to a non-viable truncated protein; for CLCN1-p.G355R, we predict structural damage, triggering important steric clashes. The SCN4A-p.R1463H produced a positive shift in the steady-state inactivation increasing window currents and a faster recovery from inactivation. These gain-of-function effects are probably due to a disruption of interaction R1463-D1356, which destabilizes the voltage sensor domain (VSD) IV and increases the flexibility of the S4-S5 linker. Finally, modelling suggested that the p.T1313M induces a strong decrease in protein flexibility on the III-IV linker. This study demonstrates that CLCN1-p.W322* and SCN4A-p.R1463H mutations can act alone or in combination as inducers of myotonia. Their co-segregation highlights the necessity for carrying out deep genetic analysis to provide accurate genetic counseling and management of patients.Funding Information
- Vicerrectoría de Investigación, Universidad de Costa Rica (B4-318)
- Associazione Italiana per la Ricerca sul Cancro (IG 21558)
- Italian Research Ministry (PRIN 20174TB8KW)
This publication has 53 references indexed in Scilit:
- Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypesExperimental Neurology, 2013
- The diagnosis and treatment of myotonic disordersMuscle & Nerve, 2013
- Shaping of action potentials by type I and type II large-conductance Ca2+-activated K+ channelsNeuroscience, 2011
- Sodium channelopathies of skeletal muscle result from gain or loss of functionPflügers Archiv - European Journal of Physiology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa crystallographica. Section D, Structural biology, 2009
- The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatmentBrain, 2009
- A seizure-induced gain-of-function in BK channels is associated with elevated firing activity in neocortical pyramidal neuronsNeurobiology of Disease, 2008
- Direct molecular diagnosis of myotonic dystrophyClinical Genetics, 2008
- Temperature‐sensitive defects in paramyotonia congenita mutants R1448C and T1313MMuscle & Nerve, 2004
- Unstable DNA may be responsible for the incomplete penetrance of the myotonic dystrophy phenotypeHuman Molecular Genetics, 1992